Does NAD+ Really Boost Energy and Slow Aging? What the Research Shows

If you have spent any time around wellness marketing lately, you have probably seen NAD+ promised as the answer to low energy, slow metabolism, and even aging itself. IV drips, oral supplements, and skin creams all use the same molecule's name. The science behind NAD+ is real and genuinely interesting. The gap between that science and what is being sold to you is where things get complicated, and it is worth walking through honestly.

What NAD+ actually does in your cells

NAD+, short for nicotinamide adenine dinucleotide, is a coenzyme found in every cell in your body. It plays a central role in converting the food you eat into usable cellular energy, and it also helps power enzymes involved in DNA repair and cellular stress response. Without adequate NAD+, your mitochondria, the energy-producing structures inside cells, cannot work efficiently.

This is not a fringe idea. NAD+ metabolism has been studied in biochemistry and aging research for decades. What is newer, and still being worked out, is whether raising NAD+ levels in healthy adults through supplements or infusions produces a meaningful clinical benefit.

Why NAD+ levels decline with age

Research consistently shows that NAD+ levels drop as people get older, and this decline has been linked in animal studies to reduced mitochondrial function, increased inflammation, and age-related disease processes (Imai & Guarente, 2014). That connection is part of why NAD+ became a target for longevity researchers in the first place.

It is important to be precise about what this means for you. Most of the detailed mechanistic work connecting NAD+ decline to specific diseases comes from animal models, particularly mice. Human aging is more complex, and a decline in a single molecule rarely explains everything on its own. The honest summary is that NAD+ decline is a real, measurable part of aging biology, but it is one piece of a much larger picture, not the single lever that controls how you age.

IV NAD+ drips: what the evidence actually shows

IV NAD+ clinics often market their drips for energy, focus, hangover recovery, and even addiction recovery support. The pharmacology behind the infusion itself is not in question: intravenous NAD+ does raise circulating NAD+ metabolites. A small pilot study tracking healthy volunteers during a six-hour NAD+ infusion confirmed measurable changes in the blood and urine NAD+ metabolome during and after the infusion (Grant et al., 2019).

What that study, and the field more broadly, has not established is whether this translates into better energy, mood, or any measurable health outcome in otherwise healthy people. Human evidence for clinical outcomes from IV NAD+ is still limited. There is no large, well-controlled clinical trial showing that IV NAD+ improves fatigue, cognitive performance, or longevity markers in a way that beats placebo. Much of what circulates about IV NAD+ for addiction or chronic fatigue comes from open-label case reports and clinic-reported outcomes, not the kind of randomized, blinded trials that let researchers separate a real drug effect from expectation and the attention that comes with any infusion visit.

That does not mean IV NAD+ does nothing. It means we genuinely do not know yet, and anyone telling you with certainty that it will fix your energy is overstating the evidence.

Oral NAD+ precursors: what the research on NR and NMN actually supports

Rather than infusing NAD+ directly, most oral supplements provide precursor molecules, usually nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN), that your body converts into NAD+. These have considerably more human trial data than IV NAD+, though the trials are still relatively small and short.

A study in healthy middle-aged and older adults found that NR supplementation over several weeks was well tolerated and reliably raised blood NAD+ levels (Martens et al., 2018). Similar pharmacokinetic work in healthy volunteers confirmed that oral NR is absorbed and does increase NAD+ metabolites in the blood (Airhart et al., 2017). A separate trial in aged human skeletal muscle found that NR supplementation changed gene expression patterns in a direction consistent with reduced inflammation (Elhassan et al., 2019).

The results get more mixed when researchers look for functional benefits rather than just NAD+ levels. A randomized, placebo-controlled trial of NR in men with obesity found it was safe but did not meaningfully improve insulin sensitivity or body composition over the study period (Dollerup et al., 2018). On the other hand, a well-designed trial of NMN in women with prediabetes found a specific improvement in muscle insulin sensitivity, though it did not change blood sugar control, body weight, or other metabolic measures (Yoshino et al., 2021).

Taken together, this body of research tells a consistent, if modest, story: oral NAD+ precursors are reasonably well tolerated and do raise NAD+ levels in the body. Whether that translates into a benefit you would actually feel, like more energy or better endurance, is still an open question that depends heavily on which outcome, dose, and population you are looking at.

Who might reasonably consider NAD+ support, and who should look elsewhere first

If you are dealing with ongoing fatigue, NAD+ is rarely the first thing worth testing. More common and better-evidenced causes, like thyroid dysfunction, iron deficiency, sleep disorders, depression, and medication side effects, explain the overwhelming majority of persistent low energy. A thorough evaluation of those causes should come first.

Once that groundwork is done, some people reasonably choose to try an oral NAD+ precursor as a low-risk addition to their routine, understanding that the evidence for a noticeable personal benefit is still developing rather than settled. People with underlying health conditions, those who are pregnant or breastfeeding, and anyone taking other medications should talk with a clinician before starting, since long-term safety data in those groups is limited.

NAD+ research is a genuinely active and promising area of aging science. It has just not yet produced the kind of large, repeated human evidence that would justify the confident claims showing up in a lot of marketing. Being honest about that gap is part of taking the science seriously.

If you are curious whether a functional medicine approach, grounded in your own labs and history rather than a one-size-fits-all protocol, makes sense for you, you can learn more about our functional medicine care. Most major plans are accepted, including Medicare, and visits happen by telehealth appointment in every state we are licensed in.